S
Stockadora

Recent Annual Reports

Browse the latest SEC filings with AI-powered analysis. Get insights into corporate performance, financial trends, and business developments.

📊 4753 Reports
🤖 AI Analyzed
Recent
📄 Page 284 of 397
Upland Software, Inc.
10-K March 3, 2026

Key Highlights

  • Successful integration of AI capabilities into customer engagement platform, lea...
  • Secured several key enterprise contracts in the second half of 2025, signaling p...
  • Strategic focus on product innovation (AI-driven features), customer retention, ...
Read Analysis
🤖 AI Generated
NeuroPace Inc
10-K March 3, 2026

Key Highlights

  • Achieved strong 22% year-over-year revenue growth, reaching $65.4 million in 202...
  • Maintained a healthy gross margin of 70.5%, indicating strong product profitabil...
  • Secured a solid cash position of $80.5 million, providing financial runway for o...
Read Analysis
🤖 AI Generated
CalciMedica, Inc.
10-K March 3, 2026

Key Highlights

  • Completed patient enrollment for lead candidate Auxora in acute pancreatitis, wi...
  • Successfully raised capital through a public stock offering, strengthening the b...
  • Initiated preclinical studies for a new candidate targeting autoimmune diseases,...
Read Analysis
🤖 AI Generated
United Parks & Resorts Inc.
10-K March 3, 2026

Key Highlights

  • Achieved strong FY2025 financial performance with $2.1 billion in revenue (+12% ...
  • Experienced robust operational growth, welcoming 25 million visitors (+8% YoY) a...
  • Maintains a solid financial position with $300 million in cash and a current rat...
Read Analysis
🤖 AI Generated
AMBEV S.A.
20-F March 3, 2026

Key Highlights

  • AMBEV S.A. boasts extensive operations across Brazil, Central America, South Lat...
  • The company manages a diverse portfolio of brands in Beer and Non-Alcoholic Beve...
  • A favorable regulatory change in Brazil, the 'Exclusion of ICMS from PIS/COFINS ...
Read Analysis
🤖 AI Generated
Evolus, Inc.
10-K March 3, 2026

Key Highlights

  • Achieved 28% revenue growth to $205 million in 2025.
  • Successfully launched Evolysse dermal fillers internationally, diversifying its ...
  • Significantly narrowed net loss to $15 million, showing improved profitability.
Read Analysis
🤖 AI Generated
Civeo Corp
10-K March 3, 2026

Key Highlights

  • Civeo demonstrated resilient financial health in 2025 with 3% revenue growth to ...
  • The Australian segment performed strongly, contributing $320 million in revenue ...
  • The company maintains a sound financial position with $70 million in cash and co...
Read Analysis
🤖 AI Generated
James River Group Holdings, Inc.
10-K March 3, 2026

Key Highlights

  • Aggressively reshaping business to focus exclusively on the specialized Excess a...
  • Completed two major strategic divestitures (Workers' Comp and JrgRe) to simplify...
  • Proactively managing legacy Commercial Auto liabilities through Loss Portfolio T...
Read Analysis
🤖 AI Generated
Amylyx Pharmaceuticals, Inc.
10-K March 3, 2026

Key Highlights

  • Strategic pivot to a revitalized pipeline, led by Avexitide for post-bariatric h...
  • Avexitide is in Phase 3 (LUCIDITY trial) with topline data expected in late 2026...
  • Strong cash position of $310 million as of December 31, 2025, bolstered by recen...
Read Analysis
🤖 AI Generated
Anheuser-Busch InBev SA/NV
20-F March 3, 2026

Key Highlights

  • Achieved solid revenue growth driven by strategic pricing and premiumization eff...
  • Successfully expanded its premium portfolio and gained market share in key growt...
  • Digital transformation initiatives, including B2B e-commerce platforms, gained s...
Read Analysis
🤖 AI Generated
Enliven Therapeutics, Inc.
10-K March 3, 2026

Key Highlights

  • Lead product ELVN-001 showed promising preliminary safety and efficacy in Phase ...
  • Strong financial position with $450.0 million in cash, projected to fund operati...
  • Anticipates initiating a pivotal Phase 2 study for ELVN-001 in H1 2026, a critic...
Read Analysis
🤖 AI Generated
Hinge Health, Inc.
10-K March 3, 2026

Key Highlights

  • Hinge Health successfully completed its IPO on May 31, 2025, listing on the NYSE...
  • The company demonstrated robust financial growth, with revenue surging by an est...
  • Hinge Health significantly strengthened its financial position post-IPO, boastin...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from annual reports with our AI-powered analysis. Track corporate performance, financial trends, and strategic developments.

Back to Homepage